Optimal timing of anti-PD-1 antibody combined with chemotherapy administration in patients with NSCLC.

已完结 10 由 chen 发布于 2024/12/25 8:58:05

DOI:10.1136/jitc-2024-009627
作者：Yachang Huo, Dan Wang, Shuangning Yang, Yujie Xu, Guohui Qin, Chenhui Zhao, Qingyang Lei, Qitai Zhao, Yaqing Liu, Kaiyuan Guo, Songyun Ouyang, Ti
文献类型：期刊论文
补充材料：只需要正文

BMJ

Abstract：Background: Anti-programmed cell death 1 (PD-1) antibody combined with chemotherapy simultaneously is regarded as the standard treatment for patients with advanced non-small cell lung cancer

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:WileyFluorine-Induced Lattice Oxygen Participation in 2D Layered Double Hydroxide/MXene Hybrids for Efficient Oxygen Evolution.